AI Overview
Can't generate an AI overview right now. Try again later.
Papillary thyroid cancer generally has an excellent prognosis with high survival rates, especially when localized or regional.
Show more
Show less
Five-year survival rates are nearly 100% for localized and regional disease, and around 76% for metastatic disease.
Ten-year survival rates for all patients with papillary thyroid cancer are estimated to be over 90%.
However, prognosis can be influenced by factors like age, tumor size, and extent of spread.
Factors Influencing Prognosis:
- Age: Younger patients generally have a better prognosis than older patients.
- Tumor Size: Smaller tumors tend to have a better prognosis than larger tumors.
- Extent of Spread: Cancer that has spread beyond the thyroid (metastatic disease) has a lower survival rate than localized or regional disease.
- Lymph Node Involvement: While not as impactful as distant spread, lymph node involvement can affect prognosis, especially in older patients.
- Histological Subtype: Certain histological subtypes of papillary thyroid cancer may have a slightly different prognosis.
- Extrathyroidal Extension: Spread of the cancer beyond the thyroid capsule (extrathyroidal extension) can negatively impact prognosis.
Prognostic Index (PI): A study in JAMA developed a prognostic index (PI) based on age, tumor size, extrathyroidal spread, and histological variant.
- Low-risk group: Showed a mortality of 0%.
- Medium-risk group: Showed a mortality of 17.1%.
- High-risk group: Showed a mortality of 76.5%.
Recurrence:
- Papillary thyroid cancer can recur, even after successful initial treatment.
- The average time to recurrence can vary from months to decades.
- Factors like lymph node recurrence can negatively impact survival, especially in older patients.
Overall, papillary thyroid cancer is a highly treatable cancer with an excellent prognosis for most patients.
According to the Thyroid Cancer Center, It is crucial to discuss specific risk factors and prognosis with a healthcare professional for personalized information.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Jun 30, 2025 · Papillary thyroid cancer ; SEER Stage. 5-Year Relative Survival Rate ; Localized. >99% ; Regional. 99% ; Distant. 71% ; All SEER stages combined. >99 ...
People also ask
What is the life expectancy of someone with papillary thyroid cancer?
Papillary thyroid cancer makes up about 90% of all thyroid cancers and is carries the best prognosis, with 99% of patients surviving more than 5 years. Indeed, 94% of our patients who are diagnosed with papillary thyroid cancer are disease-free one year after treatment.
Overall, the prognosis of papillary thyroid cancer is excellent, especially if you're younger than 40 at diagnosis and have a small tumor. PTC can often be ...
Nov 17, 2021 · The 5-year survival rate for metastatic papillary thyroid cancer is 76%, which is excellent compared to many other types of cancer. As seen ...
The overall prognosis is good for most patients, especially the ones younger than 45 years of age. This activity illustrates the role of the interprofessional ...
Papillary thyroid cancers More than 85 out of every 100 men (more than 85%) survive their cancer for 5 years or more after they are diagnosed. Almost 95 out of ...
The survival was 97.5% at 1 year, 92.8% at 5, 89.5% at 10, and 83.9% at 15 and 20 years. The prognostic factors obtained after the multivariate analysis were ...
Fortunately, papillary thyroid cancer is also the thyroid cancer with the best prognosis and most patients can be cured if treated appropriately and early ...